{"ticker": {"uuid": "f6363789-2597-4d52-817a-71fbf35f031b", "symbol": "NVNO", "name": "enVVeno Medical Corp", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Medical Devices"}, "articles": [{"title": "EnVVeno Medical : Highlights Newly Issued U.S. Patent Strengthening Competitive Position Ahead of Historic Pivotal Trial in Virtual Investor \"What This Means\" Segment", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5AFBVV95cUxPRngzLWxjYldPX2Z1V2RkT29DUWpjdnM3QWdrNi1QQmRxTmdtVEVMcjRSYkh0ZURSblowRTBKeWRDSGVoZTd2LTk1N2djTF9sbFFKMDg4S1RSQkJKVFk1ZmlDVjd1M3pZVmQxV0tzZ0VleDBZQ0hKWF84LWpoUF9xbG9FaVgyNFhza0xUWkRBVWl5eFBsZGdoMXBmUVVITlFsUWoyalhNVVF3NkxsQ2ZTX1UwQndRVmJZdWI5aW5TbTVxTkpxMEZQbjFOdUFxbXpzbmxEZm1acTJtdElNa0VURkNOVVo?oc=5", "source_name": "marketscreener.com", "published_at": "2026-07-15T12:38:15+00:00", "published_display": "15 Jul 2026 12:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "enVVeno's non-surgical valve trial gets first-ever FDA IDE approval", "summary": "enVVeno Medical (NASDAQ: NVNO) announced that its CEO, Robert Berman, discussed recent milestones for the company's enVVe replacement venous valve system in a Virtual Investor \"What This Means\" segment. These milestones include the issuance of the first U.S. patent for the enVVe ", "url": "https://www.stocktitan.net/news/NVNO/en-v-veno-medical-highlights-newly-issued-u-s-patent-strengthening-wrir8ausoe4i.html", "source_name": "Stock Titan", "published_at": "2026-07-15T12:43:06", "published_display": "15 Jul 2026 12:43", "sentiment": "positive", "sentiment_pct": 71, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "enVVeno Medical Highlights Newly Issued U.S. Patent Strengthening Competitive Position Ahead of Historic Pivotal Trial in Virtual Investor \"What This Means\" Segment", "summary": "enVVeno Medical announced that CEO Robert Berman discussed the company's recent U.S. patent issuance in a Virtual Investor \"What This Means\" segment. This patent, combined with FDA IDE approval for its enVVe system, is expected to strengthen the company's competitive position in ", "url": "https://www.accessnewswire.com/newsroom/en/biotechnology/envveno-medical-highlights-newly-issued-u.s.-patent-strengthening-competitive-positio-1191145", "source_name": "ACCESS Newswire", "published_at": "2026-07-15T08:30:00", "published_display": "15 Jul 2026 08:30", "sentiment": "positive", "sentiment_pct": 73, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "enVVeno Medical (NASDAQ: NVNO) releases updated investor presentation", "summary": "enVVeno Medical Corporation (NASDAQ: NVNO) released an updated investor presentation on July 14, 2026, which will be used in meetings with investors and analysts. This presentation is furnished as Exhibit 99.1 under Regulation FD, ensuring that key information is made available t", "url": "https://www.stocktitan.net/sec-filings/NVNO/8-k-en-v-veno-medical-corp-reports-material-event-312f8ef9e808.html", "source_name": "Stock Titan", "published_at": "2026-07-14T20:41:13", "published_display": "14 Jul 2026 20:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Reflecting On Medical Devices & Supplies - Specialty Stocks\u2019 Q1 Earnings: Integer Holdings (NYSE:ITGR)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNUFd1SUpRcWlCdEFjU1YzNTZkdjBfRkwyY2lBYjh1ZXZlZTlyVlpWSWx1bExvckFrNHNhUEdVTGNFWUxaMkVDZUV2c2hPS1h2YVhNSHNsVzFYNUFrNHBnRVM1STRsa2Zmb0VXeEQ4UFRGNDBOWXZfWVU5VFUyQ3JZZm9KamZMWXVDSEtNMWwyVktpaEZfRjVNU1BYaWJ3NnpNUmRyMEpsSzBXdw?oc=5", "source_name": "Market source", "published_at": "2026-07-14T18:07:11+00:00", "published_display": "14 Jul 2026 18:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of enVVeno Medical Corporation \u2013 BOATS:NVNO", "summary": "This article briefly presents financial data for enVVeno Medical Corporation (NVNO) on the Blue Ocean Alternative Trade System (BOATS). It specifically highlights the \"Price to earnings forward\" metric. The content is primarily a data placeholder within a financial platform.", "url": "https://www.tradingview.com/symbols/BOATS-NVNO/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-07-12T02:40:40", "published_display": "12 Jul 2026 02:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "NVNO Forecast \u2014 Price Target \u2014 Prediction for 2027", "summary": "This article provides a forecast and price target for enVVeno Medical Corporation (NVNO) for 2027, based on analyst opinions. It includes current stock performance metrics, financial data such as earnings and revenue for recent quarters, and market capitalization. The article als", "url": "https://www.tradingview.com/symbols/NASDAQ-NVNO/forecast-price-target/", "source_name": "TradingView", "published_at": "2026-07-09T06:41:15", "published_display": "09 Jul 2026 06:41", "sentiment": "negative", "sentiment_pct": 38, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A42085 Forecast \u2014 Price Target \u2014 Prediction for 2027", "summary": "This article provides an overview of enVVeno Medical Corporation (A42085) stock forecast, including a price target of 26.23 EUR from one analyst. It details the company's past earnings and revenue, noting a significant surprise in reported earnings and zero revenue for the last q", "url": "https://www.tradingview.com/symbols/LS-A42085/forecast-price-target/", "source_name": "TradingView", "published_at": "2026-07-08T09:41:00", "published_display": "08 Jul 2026 09:41", "sentiment": "negative", "sentiment_pct": 37, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "enVVeno Medical receives U.S. patent for venous valve system By Investing.com", "summary": "enVVeno Medical Corporation (NASDAQ:NVNO) has been granted a U.S. patent for its enVVe transcatheter replacement venous valve system, which is designed to treat deep venous insufficiency. This patent covers key components of the system and methods for patient treatment. The compa", "url": "https://ng.investing.com/news/stock-market-news/envveno-medical-receives-us-patent-for-venous-valve-system-93CH-2589037", "source_name": "Investing.com Nigeria", "published_at": "2026-07-07T20:43:07", "published_display": "07 Jul 2026 20:43", "sentiment": "positive", "sentiment_pct": 74, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "enVVeno Medical Secures Transformational U.S. Patent for enVVe System, Strengthening Competitive Moat Ahead of Launch of Historic FDA Pivotal Trial", "summary": "The article reports that enVVeno Medical has received a significant U.S. patent for its enVVe System, which is expected to bolster its competitive position. This development comes as the company prepares to launch a historic FDA pivotal trial. The patent is described as transform", "url": "https://www.newspressnow.com/sports/chiefs/envveno-medical-secures-transformational-u-s-patent-for-envve-system-strengthening-competitive-moat-ahead-of/article_c30f34af-054e-5a28-b6e9-982539e7fce0.html", "source_name": "News-Press NOW", "published_at": "2026-07-07T12:40:24", "published_display": "07 Jul 2026 12:40", "sentiment": "positive", "sentiment_pct": 94, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "enVVeno Medical receives U.S. patent for venous valve system", "summary": "enVVeno Medical has been granted a U.S. patent for its enVVe transcatheter replacement venous valve system, designed to treat deep venous insufficiency. The company is set to begin its TAVVE U.S. pivotal trial following FDA approval, with patient data expected by Q4 2026. Despite", "url": "https://www.investing.com/news/company-news/envveno-medical-receives-us-patent-for-venous-valve-system-93CH-4779272", "source_name": "Investing.com", "published_at": "2026-07-07T12:40:09", "published_display": "07 Jul 2026 12:40", "sentiment": "positive", "sentiment_pct": 74, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "enVVeno patent covers key enVVe valve parts before pivotal FDA trial", "summary": "enVVeno Medical (NASDAQ:NVNO) has been granted U.S. Patent No. 12,575,932, covering core components of its enVVe transcatheter replacement venous valve system. This patent strengthens the company's intellectual property ahead of the launch of its TAVVE U.S. pivotal trial, which a", "url": "https://www.stocktitan.net/news/NVNO/en-v-veno-medical-secures-transformational-u-s-patent-for-en-v-ve-7y1zxoxdai1y.html", "source_name": "Stock Titan", "published_at": "2026-07-07T12:40:08", "published_display": "07 Jul 2026 12:40", "sentiment": "positive", "sentiment_pct": 72, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "enVVeno Medical (NVNO) Secures New Patent for Innovative Venous Valve System", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1gJBVV95cUxObXFvMlhOYVc1eGtXMXdVZjctUUJBSG9DWUdzVEw0R3o1aUFkNjZpMk9tQVpKMUY0b1ZTdHdsdG95V0d2dHYtaF81bUtEY2gtV0ZjRTlfQ25Ld1BJZ192ZWNwTTZsQy1Ba01uMGJmenRpNzBlVC1NTW9xNDBXZ3Q2X2V5ZHdOVXpGelUtczJhby01TWxfSnZLbDVQNnZ1dXh1T0QwdU03Mk1jN2dtY2JqVUhrNkVzcHBNeHNaSTZVZjNlcmhKWmhSZWRWYlpxVUhwemZGelozUnBQdDA0dkticmxyNk1waDNPdER3anhGSDVwXzdPeWlKNEtzZTVER1gwanhlLW1nZnR0SGROZTVNbDM1dFp6RHpYSGRkbDlkRUFjM19peTVYdmNJY3lyZ19KUmFMRDBLb2tFZVBISGFjNnM5OUtCZlBJTkc1UDlvMGpwQ1p0dkE?oc=5", "source_name": "GuruFocus", "published_at": "2026-07-07T07:00:00+00:00", "published_display": "07 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ladenburg Thalmann Upgrades EnVVeno Medical(NVNO.US) to Buy Rating, Announces Target Price $30", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxNdDFhUGJMYjRVb3VrbGRfbmZvUHFlS3VaTEZfM0k5ZHY2Z29EcFpuZ2FfQkFKMkJvYnptSnpBS0llSFd6VnVRakp1VnVQX3h4d0M3NlpHajFfa2ZyMkkxaEdDQ1FvV3RYQ0thdVczQTNfRFhQQnk3dUJWZ3NFT0dxX2FmcFRPRVRnZEplYUtiX05XcWNkVF9BdHNkZVNaMnMyTVE0V3lFWFpIZFJHUjZjWm5CTmxUdw?oc=5", "source_name": "\u5bcc\u9014\u725b\u725b", "published_at": "2026-07-06T15:31:00+00:00", "published_display": "06 Jul 2026 15:31", "sentiment": "positive", "sentiment_pct": 66, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "enVVeno Medical: enVVeno Medical Corporation - Reverse Split Option Symbol: NVNO New Symbol: NVNO1", "summary": "This article announces a reverse stock split for enVVeno Medical Corporation. The option symbol for the company's stock will change from NVNO to NVNO1 following the split.", "url": "https://www.moomoo.com/news/notice/306332111/envveno-medical-envveno-medical-corporation-reverse-split-option-symbol-nvno", "source_name": "Moomoo", "published_at": "2026-07-01T04:09:58", "published_display": "01 Jul 2026 04:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of enVVeno Medical Corporation \u2013 NASDAQ:NVNO", "summary": "This article provides a brief snapshot of the \"Price to sales forward\" metric for enVVeno Medical Corporation (NASDAQ: NVNO) as found on TradingView. It shows that there is no data available for the period, value, or change in this specific financial metric. The content primarily", "url": "https://www.tradingview.com/symbols/NASDAQ-NVNO/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-27T14:40:27", "published_display": "27 Jun 2026 14:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to revenue forward of enVVeno Medical Corporation \u2013 NASDAQ:NVNO", "summary": "This article focuses on the enterprise value to revenue forward metric for enVVeno Medical Corporation, traded under the NASDAQ:NVNO symbol. It is presented within the context of financial data available on TradingView, indicating a specific financial analysis perspective for the", "url": "https://www.tradingview.com/symbols/NASDAQ-NVNO/financials-statistics-and-ratios/enterprise-value-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-27T07:08:44", "published_display": "27 Jun 2026 07:08", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of enVVeno Medical Corporation \u2013 FWB:5HJ0", "summary": "This article provides financial information for enVVeno Medical Corporation (FWB:5HJ0) on the Frankfurt Stock Exchange, specifically focusing on its forward price-to-sales ratio. The content is primarily a data placeholder and navigational links from TradingView, offering no deta", "url": "https://www.tradingview.com/symbols/FWB-5HJ0/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-27T04:08:44", "published_display": "27 Jun 2026 04:08", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to book forward of enVVeno Medical Corporation \u2013 FWB:5HJ0", "summary": "The article title indicates a discussion about the \"Price to book forward\" for enVVeno Medical Corporation (FWB:5HJ0) listed on the Frankfurt Stock Exchange. However, the provided content only contains navigation, market data links, and copyright information, without any actual f", "url": "https://www.tradingview.com/symbols/FWB-5HJ0/financials-statistics-and-ratios/price-book-fwd/", "source_name": "TradingView", "published_at": "2026-06-27T01:37:31", "published_display": "27 Jun 2026 01:37", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of enVVeno Medical Corporation \u2013 NASDAQ:NVNO", "summary": "This article provides financial information for enVVeno Medical Corporation (NASDAQ: NVNO), focusing on its forward price-to-earnings ratio. It appears to be a snapshot from a financial data platform, indicating the company's ticker, market, and a period value for the forward P/E", "url": "https://www.tradingview.com/symbols/NASDAQ-NVNO/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-06-26T23:40:31", "published_display": "26 Jun 2026 23:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "enVVeno Medical Corporation Actuals & Estimates (FWB:5HJ0)", "summary": "This article provides financial actuals and estimates for enVVeno Medical Corporation (FWB:5HJ0), including income statement, balance sheet, and cash flow data. It details the company's stock ticker, historical price performance, upcoming earnings report date, net income, and emp", "url": "https://www.tradingview.com/symbols/FWB-5HJ0/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-26T22:08:44", "published_display": "26 Jun 2026 22:08", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "enVVeno Medical Corporation Actuals & Estimates (NASDAQ:NVNO)", "summary": "This article provides an overview of enVVeno Medical Corporation (NASDAQ: NVNO), detailing its stock performance, financial data, and analyst estimates. It highlights the current stock price, historical highs and lows, volatility, market capitalization, and upcoming earnings repo", "url": "https://www.tradingview.com/symbols/NASDAQ-NVNO/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-26T17:40:31", "published_display": "26 Jun 2026 17:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Spotting Winners: Merit Medical Systems (NASDAQ:MMSI) And Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks In Q1", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxPZ3VmWDdGZC04R2RXUUJZTHJqVlJrdnhJYy1LaEJkcHBaWi1sWXdoWS1oLWFlVUQxdFNOQlNDdzhaTHJtMGRkX3pHc1pWbGp0bENwY1h6TlpvWVRWWmJxODh4emhGVDBFajd0VWNmUGNVcnN1SDBXRG9jZFVDa2M4MGFCVFhxbGN0ZXZqSTV2SUE1S3JjMTRnQlBiSnVmR0lv?oc=5", "source_name": "Market source", "published_at": "2026-06-25T07:00:00+00:00", "published_display": "25 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "enVVeno Medical to Present in the Webull Corporate Connect Webinar Series", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/envveno-medical-present-webull-corporate-130000026.html", "source_name": "ACCESS Newswire", "published_at": "2026-06-22T13:00:00+00:00", "published_display": "22 Jun 2026 13:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "FDA-cleared venous valve study takes center stage at enVVeno webinar", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxNSFJLcGt5MzFSbmQ4YzFKYlBRSUdlMTlScWd3Rl9iS3g5R09rY2N6N1BUVjJkRlBKRDRkYUF5dVJUd3pJS2xJWl9ENktRRkJjdmJPWXI3Z3JBWk9qNmhzaFdtU3pRTmV5cWY1Y0FlRUtOQnN6TzVhVWhtM090OUdwRVZlTXlCd2FENHVSYTNCNU1nT0Y4OHpta0JVMGtEdXpWV1dHM1FtNzhzdHVObUd1MTNkX0ZlWlJNY3VWMXNLZnM?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-22T07:00:00+00:00", "published_display": "22 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "This Undervalued Medical-Devices Stock Is Poised for a Rebound", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxPN1g2RjVsUTVvTmdXRTdJMTRpVTlOQnZIbm9hTWJDdkRaeVpINjFqbXpDUVFpMVdYMExyR2VQQVNpZ3p0V2F1SVJMelpJZWk1bExvb0dYWnJ4VVJJRURseEVQVVZwNnRZREZiQzlFTHlhSHFadGdXRmpxbXA2XzBMNA?oc=5", "source_name": "Barron's", "published_at": "2026-06-22T07:00:00+00:00", "published_display": "22 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "enVVeno Medical Corp (NVNO) Shareholder Structure: Major Shareholders & Institutional Holdings", "summary": "This article provides an overview of enVVeno Medical Corp's (NVNO) shareholder structure, detailing major individual and institutional holders as well as shareholder types. It lists top shareholders like Satterfield (Thomas A Jr) and Perceptive Advisors LLC, alongside a breakdown", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-nvno/ownership", "source_name": "TradingKey", "published_at": "2026-06-17T09:09:26", "published_display": "17 Jun 2026 09:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q1 Earnings: ICU Medical (NASDAQ:ICUI) Firing on All Cylinders", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNTWR3bzJReVB0UTNleWx6WDlmRW1rYmpLdkptZHdadzVERk1hTzdEV0M1Z2tuRUx2cldOT2d3WlVDank5Y01EWWFfWXdWNkJFdkNFcnhjMjdCQ1Y2aFBVbndiNXVBY0F5dDRpU2Fla25fVWRTUlNROXFwYXNXT2czUm5Nbl9QUFhFTEhHd1ZKTzJUSzhJWjN6QnNNUEVBTVEyR0l6YkZacUVsdw?oc=5", "source_name": "Market source", "published_at": "2026-06-16T07:00:00+00:00", "published_display": "16 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "enVVeno Medical (NVNO) Retreats 1.96% as Stock Navigates Key Support at $9.50 - OBV Divergence", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPTHVkRmJkMlNSbXhXTEMzR2xPandGMHBuM2J5aVplNC1DUGN4eUhyYXozbnVtcnNNSUFfb3JJQnZWMVlsYTRvVXhxRTR1Rmx5M0ptVlBTVDdLRUhOaGNETG9GMkRtakM5M2NHYVdxMnY2NTdIUW9LYS1kUXcxRF9fR3pGVk5UV0U4VjZfcXdVTC1EQnVyWmNoZ1JmSXJ1aFBiX1hlUm5TQUtySUNjNnU3d25xZw?oc=5", "source_name": "dars.gov.et", "published_at": "2026-06-14T07:00:00+00:00", "published_display": "14 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Director at enVVeno Medical (NASDAQ: NVNO) sells 140 shares under Rule 10b5-1 plan", "summary": "Francis Duhay, a director at enVVeno Medical Corp (NASDAQ: NVNO), sold 140 shares of common stock at $10.305 per share on June 11, 2026. This transaction was executed under a pre-planned Rule 10b5-1 trading plan established in June 2025. Following the sale, Duhay directly holds 2", "url": "https://www.stocktitan.net/sec-filings/NVNO/form-4-en-v-veno-medical-corp-insider-trading-activity-d71e1829b453.html", "source_name": "Stock Titan", "published_at": "2026-06-12T20:09:41", "published_display": "12 Jun 2026 20:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[144] enVVeno Medical Corp SEC Filing", "summary": "This article details an SEC Form 144 filing by enVVeno Medical Corp (NVNO) on June 11, 2026. The filing indicates a proposed sale of 140 shares of common stock, acquired on December 31, 2024, through an open market purchase, with an aggregate market value of $1443.00. The transac", "url": "https://www.stocktitan.net/sec-filings/NVNO/144-en-v-veno-medical-corp-sec-filing-0c0ce7d75e01.html", "source_name": "Stock Titan", "published_at": "2026-06-11T15:39:52", "published_display": "11 Jun 2026 15:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Spotting Winners: Enovis (NYSE:ENOV) And Medical Devices & Supplies - Specialty Stocks In Q1", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxQRWNsVUM3aGV5UmJHYUowOWtNRU11RzZSalpyampRQ3ZQTlBNV05zSHo4MTJJS0JqTV92LWV3MUdXWkRIckNNZi1aeVg1TmtKNFpoS3g5dTBXRW1BZXRMWGo1SVl2NjNaQ2NSNV90V0MtMzBEQndVclZzUUVXbi1FU0lyU0FndlAwaXNfUVpOTXBEZWQtQVpmanRoU0JjLWxlakFJSQ?oc=5", "source_name": "Market source", "published_at": "2026-06-11T07:00:00+00:00", "published_display": "11 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "enVVeno Medical Reports Full Year 2025 Financial Results and Highlights Strategic Advancement of enVVe(R) System", "summary": "enVVeno Medical Corporation announced its financial results for the full year 2025, reporting a net loss of $19.5 million and $28.2 million in cash and investments. The company accelerated the development of its enVVe\u00ae System, a less invasive transcatheter replacement venous valv", "url": "https://www.phillyburbs.com/press-release/story/50200/envveno-medical-reports-full-year-2025-financial-results-and-highlights-strategic-advancement-of-envver-system/", "source_name": "PhillyBurbs", "published_at": "2026-06-04T05:40:10", "published_display": "04 Jun 2026 05:40", "sentiment": "positive", "sentiment_pct": 72, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "enVVeno Medical to Participate in the Virtual Investor Closing Bell Series", "summary": "enVVeno Medical (NASDAQ:NVNO) announced that CEO Robert Berman will participate in a Virtual Investor Closing Bell event on June 9, 2026, at 4:00 PM ET. He will discuss the recent FDA IDE approval for the enVVe\u00ae System, a non-surgical replacement venous valve, and engage in a liv", "url": "https://www.accessnewswire.com/newsroom/en/biotechnology/envveno-medical-to-participate-in-the-virtual-investor-closing-bell-series-1172665", "source_name": "ACCESS Newswire", "published_at": "2026-06-02T13:38:59", "published_display": "02 Jun 2026 13:38", "sentiment": "positive", "sentiment_pct": 71, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "NVNO - enVVeno Medical Corp Stock Price and Quote", "summary": "This article provides a detailed stock price, quote, and company overview for enVVeno Medical Corp (NVNO). It includes financial metrics, stock performance data, and a chronological list of recent news and press releases related to the company's developments, FDA approvals, and f", "url": "https://finviz.com/stock?t=NVNO", "source_name": "Finviz", "published_at": "2026-06-01T16:10:52", "published_display": "01 Jun 2026 16:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "enVVeno Medical Reports First Quarter 2026 Financial Results and Provides Business Update Highlighting Strategic Advancement of the enVVe System", "summary": "enVVeno Medical reported its first-quarter 2026 financial results, ending the period with approximately $25 million in cash and investments, which is expected to fund operations into Q3 2027. The company highlighted receiving FDA IDE approval for its TAVVE U.S. Pivotal Study for ", "url": "https://www.biospace.com/press-releases/envveno-medical-reports-first-quarter-2026-financial-results-and-provides-business-update-highlighting-strategic-advancement-of-the-envve-system", "source_name": "BioSpace", "published_at": "2026-05-26T01:11:28", "published_display": "26 May 2026 01:11", "sentiment": "positive", "sentiment_pct": 70, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "enVVeno Medical (NVNO) Q3 2025 Earnings: Narrower-Than-Expected Loss Signals Cost Discipline Progress - Return On Assets", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2wFBVV95cUxQTC13SVNKaEVKTENxYW1GcjE3Zm5DT1F0ZW5fME1PZklTM2lYcXNCVHIzX0NNS01CMjY2WFRGNmN3R1dyZmk5cWVjWkstTHRtUm9pMEd1eDY0c3hUVXpoYzktVXpjTURrUUdVOEJjdjZfYkFNaG5nYkpwYnFxbTZHTTltUjNsdk44Rl9DV0hIQkRIOEJXOEJRZFJKZlBjYTVsX2Y2X0RHRF9scUFuY2tjVDF0cENlc01pX05rWFFLaG5hMG5xWm5RdVFxblZVdW41TTRMVk9aRkY3akk?oc=5", "source_name": "Donan\u0131mHaber", "published_at": "2026-05-23T07:00:00+00:00", "published_display": "23 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Specialty Stocks Q1 Highlights: Haemonetics (NYSE:HAE)", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxNMTBnNnM2WGg4UWl4LXNNdUdWLVozU3ptQlRZQTk2SFFsOEZTLTVlbU5tNnhSTVRXX3RYczQ5b2hCR254bS1QYmZqV2JfdVFYTEx2U0hFeW1VREwybmRDWEE3MEpSWldySDJNTHFXbWcta2tNY0cwM0hVWld5VnVOWE1zY1VNQS1wQkIyZHN5a0dRNktDdnBvaTcyY3RKa292aThMTmNGeUpUUVU1Unhr?oc=5", "source_name": "Market source", "published_at": "2026-05-22T07:00:00+00:00", "published_display": "22 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q1 Earnings Review: Medical Devices & Supplies - Diversified Stocks Led by Baxter (NYSE:BAX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNYjhBT3BjMWFVU1FFUUFub0d6QUVEUTdwWFVMRG5fN2dHSnIxTXQwMWU1aElKaEV1a2dYLTFHMlBzMVFTZEtaX0xRRDFhZDl1WFdDYWF2RDZxOG9SRUtycmZacTRzM2FaaEU3OS1GZ2taLWtSMjZ4enhVNHRvdzJsanp4cEhNcGI1dllTOUplWUUtNjRlRm85MlFEVWxSYUV2d243QVd3?oc=5", "source_name": "Market source", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Specialty Stocks Q1 Teardown: Bausch + Lomb (NYSE:BLCO) Vs The Rest", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxPUFI2R08xV3JsZHYxbnFGcmk1Q3prRzBQVVlJNk5NTFlYOXBaczlzZE1PREIxb0loeUNQeUw3QWczNUowYXlEOU1KY1dTY2gybUQ5OEM0Z3Z2TlNleUVIRWJMc0VqZTdZcnVOZ2JBeUpIeFNCVjk3SVYxTmc5SG1RTjBHY2l3QkdxX09lZkpMekpYOElqQmJHc0dHUm8tVzJzSFZRaUdZZzNodTdyRjZz?oc=5", "source_name": "Market source", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Perceptive entities disclose 9.99% stake in enVVeno (NASDAQ: NVNO)", "summary": "Perceptive Advisors, Joseph Edelman, and Perceptive Life Sciences Master Fund, Ltd. have filed a Schedule 13G/A, disclosing a beneficial ownership of 9.99% in enVVeno Medical Corporation (NASDAQ: NVNO). This stake, based on 667,669 outstanding shares as of May 1, 2026, is constra", "url": "https://www.stocktitan.net/sec-filings/NVNO/schedule-13g-a-en-v-veno-medical-corp-amended-passive-investment-disc-b4d8dc23f4e1.html", "source_name": "Stock Titan", "published_at": "2026-05-15T19:40:44", "published_display": "15 May 2026 19:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kingdon group holds 36,166 shares in enVVeno (NASDAQ: NVNO)", "summary": "Kingdon-affiliated parties have disclosed beneficial ownership of 36,166 shares in enVVeno Medical Corp (NASDAQ: NVNO), amounting to a 5.5% stake in the company's common stock. This information was reported through an amended Schedule 13G/A filing with the SEC, indicating shared ", "url": "https://www.stocktitan.net/sec-filings/NVNO/schedule-13g-a-en-v-veno-medical-corp-amended-passive-investment-disc-f96caf213ffb.html", "source_name": "Stock Titan", "published_at": "2026-05-15T17:40:44", "published_display": "15 May 2026 17:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "enVVeno Medical Discusses FDA IDE Approval in Virtual Investor \"What This Means\" Segment", "summary": "enVVeno Medical announced that CEO Robert Berman discussed the company's recent FDA IDE approval for a US pivotal study of a non-surgical replacement venous valve during a Virtual Investor \"What This Means\" segment. This approval is a significant step towards developing the first", "url": "https://www.accessnewswire.com/newsroom/en/biotechnology/envveno-medical-discusses-fda-ide-approval-in-virtual-investor-%22what-this-means%22-segm-1166040", "source_name": "ACCESS Newswire", "published_at": "2026-05-12T13:10:39", "published_display": "12 May 2026 13:10", "sentiment": "positive", "sentiment_pct": 71, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "One enVVeno Medical Insider Raised Their Stake In The Previous Year", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/one-envveno-medical-insider-raised-185848824.html", "source_name": "Simply Wall St.", "published_at": "2026-05-06T18:58:48+00:00", "published_display": "06 May 2026 18:58", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Diversified Stocks Q1 Results: Benchmarking Stryker (NYSE:SYK)", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2wFBVV95cUxNb1NaVXV6UW42emtDUzh5ckhKVjc2X29fSlFRRDVIVnRLWXpoWEYxUnVKNGZuLVN6ZWhxVno1SGluMEdLcmNrOGN1ZjlsWFpVRWxYbW9aYy01VFFpVzlncWtBYzF3YkJfNzhwTi1BcWlpVF9pUTU4QnNGWkJSV3YwRXVCUzk2Z2NUMWFjVkJOV2hSbFRrRnIxSWxNUGRoQmhQeDVBRjhYSnhvMDJqUThjYjBHRjhTRTBDdDZJd1k3LU5DTjU2cUx6TXFNdHhVS1FfdlFmaWZLNk41cFk?oc=5", "source_name": "StockStory", "published_at": "2026-05-05T07:00:00+00:00", "published_display": "05 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "enVVeno Medical Receives First-Ever FDA IDE Approval for a U.S. Pivotal Study of a Non-Surgical Replacement Venous Valve", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/envveno-medical-receives-first-ever-120500979.html", "source_name": "ACCESS Newswire", "published_at": "2026-04-29T12:05:00+00:00", "published_display": "29 Apr 2026 12:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Specialty Q4 Earnings: Globus Medical (NYSE:GMED) is the Best in the Biz", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNcDFMNmtOVk5PVFM1YzMyVWhyS3dwY0dMVE5BUng5U1JoOFRQMXNFRGxTMmlBRUV0bENRSWFXTDFZOXBQQkNZT0FOWDdISjRCcU9pRV9aNHBwUVBuZkVEV3g1dklVY19KOE9iWUNpNUtMS2NuOEcxMlQtNU8ydURybEdkNVoxZThWLTBIeVhid2NjQ0FWWTUzb2dxcmlMQThFQmZ4bldzRjcwUQ?oc=5", "source_name": "Market source", "published_at": "2026-04-27T07:00:00+00:00", "published_display": "27 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look Back at Medical Devices & Supplies - Imaging, Diagnostics Stocks\u2019 Q4 Earnings: Hologic (NASDAQ:HOLX) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxOdkl6Ym5HSGVhZUw3TzNlNVFPSjdDQk5NMTVSRW1xVnh3RE5RNU9veVR0TDEtcVdxV3BYelI0bWxCYXgwWmhZQ3ZONUVRdlhjX0ZiMklRVDJQRXN0LXcyVWVnb0E2WTdiRERtZk1pNGpmVHhWbHl5eHJuNnBtTDVPMUluTmRsQUVqYjNlSl8zR3djclh0X2ZIc1gzTlhPanR6ZTJ6R1FB?oc=5", "source_name": "Market source", "published_at": "2026-04-07T07:00:00+00:00", "published_display": "07 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q4 Earnings Highlights: Artivion (NYSE:AORT) Vs The Rest Of The Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxPaTgxS3dlMlZ5dDZ3dFlGdG9yRWFubkVqMk9yOTN6OEtyemljTWJGYUcxb2pmd2FTNTFKMlhIVGxrdlJsOG5iY1VQaXE4ZmYycTVpRkE0aEJ3QlB5bC10ZXN2dTFYNy0wRWdrNURVUlo5dEMzQklxQ0kwQTRkOXE0UDdTMkRGRWxoQ1ZQeG4tOXNONlR2SkxfZW5ST1B6N3BBeFZZQ3N1UFE?oc=5", "source_name": "Market source", "published_at": "2026-04-02T07:00:00+00:00", "published_display": "02 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q4 Rundown: Bausch + Lomb (NYSE:BLCO) Vs Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOd1pNRFRBVUF2RG5RNWNhSVJaWFM5aUFRVF9xSF8zVHVMcVBoSXdaRXJrbV8wLUFOS2tHOHIzZEhZSF9rZ2dVbVNIOEdEbE9GMmpsMEtIUE9OTGRjcUlyVnNSa2FyX3hjcmF2YTNDOGQ1UDVjMHI4ak44bUl1bnVoQ3VfSjZGMXR5T19xOWkzaUtSZ2NiMF80bUtvVWU?oc=5", "source_name": "Market source", "published_at": "2026-04-02T07:00:00+00:00", "published_display": "02 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q4 Earnings Highlights: CooperCompanies (NASDAQ:COO) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxOellVLTAtRXF1dTFacmVLUmptUVpDSkxGX0MtY2hCY2l3ajU4M25SMG95OHdlc1RHN1dmaHZZMF9uQ0o3R1FBa0NzQUtZMjIzMjU1bmttbGZsZUplQkd5Vmd2NEJoQ0NnbVhmVXppdWhiQkdpcGpQVFJVSHRBXy1pbnFJbXI0R2w3MmlvMEdCY2dGYVE4cWY2MENmeEp1ME9mZEFqSDVtdThTMk9kbUhIdXMtR0k?oc=5", "source_name": "Market source", "published_at": "2026-03-25T07:00:00+00:00", "published_display": "25 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Unpacking Q4 Earnings: Integer Holdings (NYSE:ITGR) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAJBVV95cUxNdFRrRlJvM3J3cGJnVEJ6ZndqMnQxWkE4Wm8zTGtPTVc0OTlLN1pwNXIyclNJMFZkcG5qQTRTWThmNm9WN0hKYXBja3N3Y20zSlkxc2JaQlpYTnAyWnpvUVBvR1JWNmVxZGhSYVlYQklMd01GeFBVNGJWOFBWYUkwYmRrM2xrSktiQWpfTkZtNG1HWThNT0tqLUpYek5qcnFWMGE0QV9CaElrMUpfTEhnOC1pS2t1bkE2VVJHdEhWdEtoX2xKNE1MWk1OSlBSNTVZVU83WEpnb3E4aURwQ3ZyZUFDbndpTTZEa0lZRTJvU2VuTDhreXdCQ25iV3Y4YWxENm1xYQ?oc=5", "source_name": "StockStory", "published_at": "2026-03-16T07:00:00+00:00", "published_display": "16 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q4 Earnings Highs And Lows: Abbott Laboratories (NYSE:ABT) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxPeVpVN2I3X3lJNXd3TXJmRWV4X0RvRDdYR3l5a1k1SjMxUlhsWHdrUUNuZ1JIaUg4czdhZlA2VDVIallROFFuNmZXcnNzS1d3Vm0wS0tLMmlFVWdkUThsRDZYdTdZV3k3WkRjaUZSMUQ3dkRKYm5ZOVBjMVVBdTRjYQ?oc=5", "source_name": "Market source", "published_at": "2026-03-12T07:00:00+00:00", "published_display": "12 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Unpacking Q4 Earnings: Enovis (NYSE:ENOV) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxNMzBPcXU1cnZKekZnaGlNVk05ZWFTWThNOS0tTlpvQjdaLVZIWlVXUk50NnVoQ0pPWWJpZUpWcVJyVDJMd2RJREVDbEEzTlU5UGhBbWtxWVEyVkdaMTVuNXZpaWFMNTZUQ2d0OW9Rc29kalJRY21naWlHZDBLS3RuZV9wdTdIUQ?oc=5", "source_name": "Market source", "published_at": "2026-03-10T07:00:00+00:00", "published_display": "10 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q4 Highlights: Merit Medical Systems (NASDAQ:MMSI)", "summary": "", "url": "https://news.google.com/rss/articles/CBMilgFBVV95cUxQdTQyU1EtSEFYQTdZR0NhU1ZpMVdGNXhiTnlkNm9RWFRka3RfYlZBeklfTFZTRkVaOHBGNi15enNqMGlxVnJad0M5cmp3dUZzYW9Va2tOU19sMnE4V1czcFB4VWRKaVBzYnRtZ0RfVnB5TkloY3U5dW4wQllJMDJaS3BQSVNOMHlVRFQ4aDYtSV9HNTViZXc?oc=5", "source_name": "Market source", "published_at": "2026-03-05T08:00:00+00:00", "published_display": "05 Mar 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "enVVeno Medical Announces Reverse Stock Split", "summary": "", "url": "https://news.google.com/rss/articles/CBMijgFBVV95cUxObGVub0hmNm1UenF1enAxRzY1NldoZF8zRjFrclRwNnFNY2REaGhSQ3YtNG0ySlY0OExFQWt2c1BleFdwZXZlXzFJTnNrNjJrMFpOdUdFb3RoTzJsa0JqNTNZZEh5Wlg2TkRDQzc2LWpzeTRoX3dMSDJNWHRBb0N1V0t3a3EzVFNCbFVVNDFB?oc=5", "source_name": "Market source", "published_at": "2026-01-15T08:00:00+00:00", "published_display": "15 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Should I buy enVVeno Medical (NVNO)", "summary": "", "url": "https://news.google.com/rss/articles/CBMibEFVX3lxTE5CLXFMQ005aFJ5ZXdsOHluUWdPb1l2LWZFVVlSbi0tTjJCZ2d2RHVhQXV5Mzk3bmFFR0RZcG1SMHFIRmt4OFRsNkpkNTI0YWhqRVRwZUdaMng0bm1TbXV5R0Q3eXhKSkNKQjRYcQ?oc=5", "source_name": "Zacks Investment Research", "published_at": "2025-08-25T07:00:00+00:00", "published_display": "25 Aug 2025 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Envveno Medical Corporation (NVNO) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE5CcldPbGg5Ymc5TlVISjl6RldzXzdjYXZER1VBSTFzekhNNUFMVWl0YzVDMi16N3FCRnQ2SVlEZW56N052NHNOZ3QyQWxTdzUxRC00?oc=5", "source_name": "Stock Titan", "published_at": "2025-04-25T02:37:16+00:00", "published_display": "25 Apr 2025 02:37", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "enVVeno Medical (NVNO) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiWkFVX3lxTE5HMVdJVXFKa2JSNjRRRGM1MWQzZWFqZ0xwT2F2RGZXNThuREQ0RkdUZElDS01qcE1OWkVoVzVIdWpxMlkwbUVscEZOQVBqQTBzdGxMM0gyRXRHdw?oc=5", "source_name": "MarketBeat", "published_at": "2021-10-02T17:34:54+00:00", "published_display": "02 Oct 2021 17:34", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "EnVVeno Medical : Highlights Newly Issued U.S. Patent Strengthening Competitive Position Ahead of Historic Pivotal Trial in Virtual Investor \"What This Means\" Segment", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5AFBVV95cUxPRngzLWxjYldPX2Z1V2RkT29DUWpjdnM3QWdrNi1QQmRxTmdtVEVMcjRSYkh0ZURSblowRTBKeWRDSGVoZTd2LTk1N2djTF9sbFFKMDg4S1RSQkJKVFk1ZmlDVjd1M3pZVmQxV0tzZ0VleDBZQ0hKWF84LWpoUF9xbG9FaVgyNFhza0xUWkRBVWl5eFBsZGdoMXBmUVVITlFsUWoyalhNVVF3NkxsQ2ZTX1UwQndRVmJZdWI5aW5TbTVxTkpxMEZQbjFOdUFxbXpzbmxEZm1acTJtdElNa0VURkNOVVo?oc=5", "source_name": "marketscreener.com", "published_at": "2026-07-15T12:38:15+00:00", "published_display": "15 Jul 2026 12:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "enVVeno's non-surgical valve trial gets first-ever FDA IDE approval", "summary": "enVVeno Medical (NASDAQ: NVNO) announced that its CEO, Robert Berman, discussed recent milestones for the company's enVVe replacement venous valve system in a Virtual Investor \"What This Means\" segment. These milestones include the issuance of the first U.S. patent for the enVVe ", "url": "https://www.stocktitan.net/news/NVNO/en-v-veno-medical-highlights-newly-issued-u-s-patent-strengthening-wrir8ausoe4i.html", "source_name": "Stock Titan", "published_at": "2026-07-15T12:43:06", "published_display": "15 Jul 2026 12:43", "sentiment": "positive", "sentiment_pct": 71, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "enVVeno Medical Highlights Newly Issued U.S. Patent Strengthening Competitive Position Ahead of Historic Pivotal Trial in Virtual Investor \"What This Means\" Segment", "summary": "enVVeno Medical announced that CEO Robert Berman discussed the company's recent U.S. patent issuance in a Virtual Investor \"What This Means\" segment. This patent, combined with FDA IDE approval for its enVVe system, is expected to strengthen the company's competitive position in ", "url": "https://www.accessnewswire.com/newsroom/en/biotechnology/envveno-medical-highlights-newly-issued-u.s.-patent-strengthening-competitive-positio-1191145", "source_name": "ACCESS Newswire", "published_at": "2026-07-15T08:30:00", "published_display": "15 Jul 2026 08:30", "sentiment": "positive", "sentiment_pct": 73, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "enVVeno Medical (NASDAQ: NVNO) releases updated investor presentation", "summary": "enVVeno Medical Corporation (NASDAQ: NVNO) released an updated investor presentation on July 14, 2026, which will be used in meetings with investors and analysts. This presentation is furnished as Exhibit 99.1 under Regulation FD, ensuring that key information is made available t", "url": "https://www.stocktitan.net/sec-filings/NVNO/8-k-en-v-veno-medical-corp-reports-material-event-312f8ef9e808.html", "source_name": "Stock Titan", "published_at": "2026-07-14T20:41:13", "published_display": "14 Jul 2026 20:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Reflecting On Medical Devices & Supplies - Specialty Stocks\u2019 Q1 Earnings: Integer Holdings (NYSE:ITGR)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNUFd1SUpRcWlCdEFjU1YzNTZkdjBfRkwyY2lBYjh1ZXZlZTlyVlpWSWx1bExvckFrNHNhUEdVTGNFWUxaMkVDZUV2c2hPS1h2YVhNSHNsVzFYNUFrNHBnRVM1STRsa2Zmb0VXeEQ4UFRGNDBOWXZfWVU5VFUyQ3JZZm9KamZMWXVDSEtNMWwyVktpaEZfRjVNU1BYaWJ3NnpNUmRyMEpsSzBXdw?oc=5", "source_name": "Market source", "published_at": "2026-07-14T18:07:11+00:00", "published_display": "14 Jul 2026 18:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of enVVeno Medical Corporation \u2013 BOATS:NVNO", "summary": "This article briefly presents financial data for enVVeno Medical Corporation (NVNO) on the Blue Ocean Alternative Trade System (BOATS). It specifically highlights the \"Price to earnings forward\" metric. The content is primarily a data placeholder within a financial platform.", "url": "https://www.tradingview.com/symbols/BOATS-NVNO/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-07-12T02:40:40", "published_display": "12 Jul 2026 02:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "NVNO Forecast \u2014 Price Target \u2014 Prediction for 2027", "summary": "This article provides a forecast and price target for enVVeno Medical Corporation (NVNO) for 2027, based on analyst opinions. It includes current stock performance metrics, financial data such as earnings and revenue for recent quarters, and market capitalization. The article als", "url": "https://www.tradingview.com/symbols/NASDAQ-NVNO/forecast-price-target/", "source_name": "TradingView", "published_at": "2026-07-09T06:41:15", "published_display": "09 Jul 2026 06:41", "sentiment": "negative", "sentiment_pct": 38, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A42085 Forecast \u2014 Price Target \u2014 Prediction for 2027", "summary": "This article provides an overview of enVVeno Medical Corporation (A42085) stock forecast, including a price target of 26.23 EUR from one analyst. It details the company's past earnings and revenue, noting a significant surprise in reported earnings and zero revenue for the last q", "url": "https://www.tradingview.com/symbols/LS-A42085/forecast-price-target/", "source_name": "TradingView", "published_at": "2026-07-08T09:41:00", "published_display": "08 Jul 2026 09:41", "sentiment": "negative", "sentiment_pct": 37, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "enVVeno Medical receives U.S. patent for venous valve system By Investing.com", "summary": "enVVeno Medical Corporation (NASDAQ:NVNO) has been granted a U.S. patent for its enVVe transcatheter replacement venous valve system, which is designed to treat deep venous insufficiency. This patent covers key components of the system and methods for patient treatment. The compa", "url": "https://ng.investing.com/news/stock-market-news/envveno-medical-receives-us-patent-for-venous-valve-system-93CH-2589037", "source_name": "Investing.com Nigeria", "published_at": "2026-07-07T20:43:07", "published_display": "07 Jul 2026 20:43", "sentiment": "positive", "sentiment_pct": 74, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "enVVeno Medical Secures Transformational U.S. Patent for enVVe System, Strengthening Competitive Moat Ahead of Launch of Historic FDA Pivotal Trial", "summary": "The article reports that enVVeno Medical has received a significant U.S. patent for its enVVe System, which is expected to bolster its competitive position. This development comes as the company prepares to launch a historic FDA pivotal trial. The patent is described as transform", "url": "https://www.newspressnow.com/sports/chiefs/envveno-medical-secures-transformational-u-s-patent-for-envve-system-strengthening-competitive-moat-ahead-of/article_c30f34af-054e-5a28-b6e9-982539e7fce0.html", "source_name": "News-Press NOW", "published_at": "2026-07-07T12:40:24", "published_display": "07 Jul 2026 12:40", "sentiment": "positive", "sentiment_pct": 94, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "enVVeno Medical receives U.S. patent for venous valve system", "summary": "enVVeno Medical has been granted a U.S. patent for its enVVe transcatheter replacement venous valve system, designed to treat deep venous insufficiency. The company is set to begin its TAVVE U.S. pivotal trial following FDA approval, with patient data expected by Q4 2026. Despite", "url": "https://www.investing.com/news/company-news/envveno-medical-receives-us-patent-for-venous-valve-system-93CH-4779272", "source_name": "Investing.com", "published_at": "2026-07-07T12:40:09", "published_display": "07 Jul 2026 12:40", "sentiment": "positive", "sentiment_pct": 74, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "enVVeno patent covers key enVVe valve parts before pivotal FDA trial", "summary": "enVVeno Medical (NASDAQ:NVNO) has been granted U.S. Patent No. 12,575,932, covering core components of its enVVe transcatheter replacement venous valve system. This patent strengthens the company's intellectual property ahead of the launch of its TAVVE U.S. pivotal trial, which a", "url": "https://www.stocktitan.net/news/NVNO/en-v-veno-medical-secures-transformational-u-s-patent-for-en-v-ve-7y1zxoxdai1y.html", "source_name": "Stock Titan", "published_at": "2026-07-07T12:40:08", "published_display": "07 Jul 2026 12:40", "sentiment": "positive", "sentiment_pct": 72, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "enVVeno Medical (NVNO) Secures New Patent for Innovative Venous Valve System", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1gJBVV95cUxObXFvMlhOYVc1eGtXMXdVZjctUUJBSG9DWUdzVEw0R3o1aUFkNjZpMk9tQVpKMUY0b1ZTdHdsdG95V0d2dHYtaF81bUtEY2gtV0ZjRTlfQ25Ld1BJZ192ZWNwTTZsQy1Ba01uMGJmenRpNzBlVC1NTW9xNDBXZ3Q2X2V5ZHdOVXpGelUtczJhby01TWxfSnZLbDVQNnZ1dXh1T0QwdU03Mk1jN2dtY2JqVUhrNkVzcHBNeHNaSTZVZjNlcmhKWmhSZWRWYlpxVUhwemZGelozUnBQdDA0dkticmxyNk1waDNPdER3anhGSDVwXzdPeWlKNEtzZTVER1gwanhlLW1nZnR0SGROZTVNbDM1dFp6RHpYSGRkbDlkRUFjM19peTVYdmNJY3lyZ19KUmFMRDBLb2tFZVBISGFjNnM5OUtCZlBJTkc1UDlvMGpwQ1p0dkE?oc=5", "source_name": "GuruFocus", "published_at": "2026-07-07T07:00:00+00:00", "published_display": "07 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ladenburg Thalmann Upgrades EnVVeno Medical(NVNO.US) to Buy Rating, Announces Target Price $30", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxNdDFhUGJMYjRVb3VrbGRfbmZvUHFlS3VaTEZfM0k5ZHY2Z29EcFpuZ2FfQkFKMkJvYnptSnpBS0llSFd6VnVRakp1VnVQX3h4d0M3NlpHajFfa2ZyMkkxaEdDQ1FvV3RYQ0thdVczQTNfRFhQQnk3dUJWZ3NFT0dxX2FmcFRPRVRnZEplYUtiX05XcWNkVF9BdHNkZVNaMnMyTVE0V3lFWFpIZFJHUjZjWm5CTmxUdw?oc=5", "source_name": "\u5bcc\u9014\u725b\u725b", "published_at": "2026-07-06T15:31:00+00:00", "published_display": "06 Jul 2026 15:31", "sentiment": "positive", "sentiment_pct": 66, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "enVVeno Medical: enVVeno Medical Corporation - Reverse Split Option Symbol: NVNO New Symbol: NVNO1", "summary": "This article announces a reverse stock split for enVVeno Medical Corporation. The option symbol for the company's stock will change from NVNO to NVNO1 following the split.", "url": "https://www.moomoo.com/news/notice/306332111/envveno-medical-envveno-medical-corporation-reverse-split-option-symbol-nvno", "source_name": "Moomoo", "published_at": "2026-07-01T04:09:58", "published_display": "01 Jul 2026 04:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of enVVeno Medical Corporation \u2013 NASDAQ:NVNO", "summary": "This article provides a brief snapshot of the \"Price to sales forward\" metric for enVVeno Medical Corporation (NASDAQ: NVNO) as found on TradingView. It shows that there is no data available for the period, value, or change in this specific financial metric. The content primarily", "url": "https://www.tradingview.com/symbols/NASDAQ-NVNO/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-27T14:40:27", "published_display": "27 Jun 2026 14:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to revenue forward of enVVeno Medical Corporation \u2013 NASDAQ:NVNO", "summary": "This article focuses on the enterprise value to revenue forward metric for enVVeno Medical Corporation, traded under the NASDAQ:NVNO symbol. It is presented within the context of financial data available on TradingView, indicating a specific financial analysis perspective for the", "url": "https://www.tradingview.com/symbols/NASDAQ-NVNO/financials-statistics-and-ratios/enterprise-value-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-27T07:08:44", "published_display": "27 Jun 2026 07:08", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of enVVeno Medical Corporation \u2013 FWB:5HJ0", "summary": "This article provides financial information for enVVeno Medical Corporation (FWB:5HJ0) on the Frankfurt Stock Exchange, specifically focusing on its forward price-to-sales ratio. The content is primarily a data placeholder and navigational links from TradingView, offering no deta", "url": "https://www.tradingview.com/symbols/FWB-5HJ0/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-27T04:08:44", "published_display": "27 Jun 2026 04:08", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to book forward of enVVeno Medical Corporation \u2013 FWB:5HJ0", "summary": "The article title indicates a discussion about the \"Price to book forward\" for enVVeno Medical Corporation (FWB:5HJ0) listed on the Frankfurt Stock Exchange. However, the provided content only contains navigation, market data links, and copyright information, without any actual f", "url": "https://www.tradingview.com/symbols/FWB-5HJ0/financials-statistics-and-ratios/price-book-fwd/", "source_name": "TradingView", "published_at": "2026-06-27T01:37:31", "published_display": "27 Jun 2026 01:37", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of enVVeno Medical Corporation \u2013 NASDAQ:NVNO", "summary": "This article provides financial information for enVVeno Medical Corporation (NASDAQ: NVNO), focusing on its forward price-to-earnings ratio. It appears to be a snapshot from a financial data platform, indicating the company's ticker, market, and a period value for the forward P/E", "url": "https://www.tradingview.com/symbols/NASDAQ-NVNO/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-06-26T23:40:31", "published_display": "26 Jun 2026 23:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "enVVeno Medical Corporation Actuals & Estimates (FWB:5HJ0)", "summary": "This article provides financial actuals and estimates for enVVeno Medical Corporation (FWB:5HJ0), including income statement, balance sheet, and cash flow data. It details the company's stock ticker, historical price performance, upcoming earnings report date, net income, and emp", "url": "https://www.tradingview.com/symbols/FWB-5HJ0/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-26T22:08:44", "published_display": "26 Jun 2026 22:08", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "enVVeno Medical Corporation Actuals & Estimates (NASDAQ:NVNO)", "summary": "This article provides an overview of enVVeno Medical Corporation (NASDAQ: NVNO), detailing its stock performance, financial data, and analyst estimates. It highlights the current stock price, historical highs and lows, volatility, market capitalization, and upcoming earnings repo", "url": "https://www.tradingview.com/symbols/NASDAQ-NVNO/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-26T17:40:31", "published_display": "26 Jun 2026 17:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Spotting Winners: Merit Medical Systems (NASDAQ:MMSI) And Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks In Q1", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxPZ3VmWDdGZC04R2RXUUJZTHJqVlJrdnhJYy1LaEJkcHBaWi1sWXdoWS1oLWFlVUQxdFNOQlNDdzhaTHJtMGRkX3pHc1pWbGp0bENwY1h6TlpvWVRWWmJxODh4emhGVDBFajd0VWNmUGNVcnN1SDBXRG9jZFVDa2M4MGFCVFhxbGN0ZXZqSTV2SUE1S3JjMTRnQlBiSnVmR0lv?oc=5", "source_name": "Market source", "published_at": "2026-06-25T07:00:00+00:00", "published_display": "25 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "enVVeno Medical to Present in the Webull Corporate Connect Webinar Series", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/envveno-medical-present-webull-corporate-130000026.html", "source_name": "ACCESS Newswire", "published_at": "2026-06-22T13:00:00+00:00", "published_display": "22 Jun 2026 13:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "FDA-cleared venous valve study takes center stage at enVVeno webinar", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxNSFJLcGt5MzFSbmQ4YzFKYlBRSUdlMTlScWd3Rl9iS3g5R09rY2N6N1BUVjJkRlBKRDRkYUF5dVJUd3pJS2xJWl9ENktRRkJjdmJPWXI3Z3JBWk9qNmhzaFdtU3pRTmV5cWY1Y0FlRUtOQnN6TzVhVWhtM090OUdwRVZlTXlCd2FENHVSYTNCNU1nT0Y4OHpta0JVMGtEdXpWV1dHM1FtNzhzdHVObUd1MTNkX0ZlWlJNY3VWMXNLZnM?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-22T07:00:00+00:00", "published_display": "22 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "This Undervalued Medical-Devices Stock Is Poised for a Rebound", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxPN1g2RjVsUTVvTmdXRTdJMTRpVTlOQnZIbm9hTWJDdkRaeVpINjFqbXpDUVFpMVdYMExyR2VQQVNpZ3p0V2F1SVJMelpJZWk1bExvb0dYWnJ4VVJJRURseEVQVVZwNnRZREZiQzlFTHlhSHFadGdXRmpxbXA2XzBMNA?oc=5", "source_name": "Barron's", "published_at": "2026-06-22T07:00:00+00:00", "published_display": "22 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "enVVeno Medical Corp (NVNO) Shareholder Structure: Major Shareholders & Institutional Holdings", "summary": "This article provides an overview of enVVeno Medical Corp's (NVNO) shareholder structure, detailing major individual and institutional holders as well as shareholder types. It lists top shareholders like Satterfield (Thomas A Jr) and Perceptive Advisors LLC, alongside a breakdown", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-nvno/ownership", "source_name": "TradingKey", "published_at": "2026-06-17T09:09:26", "published_display": "17 Jun 2026 09:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q1 Earnings: ICU Medical (NASDAQ:ICUI) Firing on All Cylinders", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNTWR3bzJReVB0UTNleWx6WDlmRW1rYmpLdkptZHdadzVERk1hTzdEV0M1Z2tuRUx2cldOT2d3WlVDank5Y01EWWFfWXdWNkJFdkNFcnhjMjdCQ1Y2aFBVbndiNXVBY0F5dDRpU2Fla25fVWRTUlNROXFwYXNXT2czUm5Nbl9QUFhFTEhHd1ZKTzJUSzhJWjN6QnNNUEVBTVEyR0l6YkZacUVsdw?oc=5", "source_name": "Market source", "published_at": "2026-06-16T07:00:00+00:00", "published_display": "16 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "enVVeno Medical (NVNO) Retreats 1.96% as Stock Navigates Key Support at $9.50 - OBV Divergence", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPTHVkRmJkMlNSbXhXTEMzR2xPandGMHBuM2J5aVplNC1DUGN4eUhyYXozbnVtcnNNSUFfb3JJQnZWMVlsYTRvVXhxRTR1Rmx5M0ptVlBTVDdLRUhOaGNETG9GMkRtakM5M2NHYVdxMnY2NTdIUW9LYS1kUXcxRF9fR3pGVk5UV0U4VjZfcXdVTC1EQnVyWmNoZ1JmSXJ1aFBiX1hlUm5TQUtySUNjNnU3d25xZw?oc=5", "source_name": "dars.gov.et", "published_at": "2026-06-14T07:00:00+00:00", "published_display": "14 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Director at enVVeno Medical (NASDAQ: NVNO) sells 140 shares under Rule 10b5-1 plan", "summary": "Francis Duhay, a director at enVVeno Medical Corp (NASDAQ: NVNO), sold 140 shares of common stock at $10.305 per share on June 11, 2026. This transaction was executed under a pre-planned Rule 10b5-1 trading plan established in June 2025. Following the sale, Duhay directly holds 2", "url": "https://www.stocktitan.net/sec-filings/NVNO/form-4-en-v-veno-medical-corp-insider-trading-activity-d71e1829b453.html", "source_name": "Stock Titan", "published_at": "2026-06-12T20:09:41", "published_display": "12 Jun 2026 20:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[144] enVVeno Medical Corp SEC Filing", "summary": "This article details an SEC Form 144 filing by enVVeno Medical Corp (NVNO) on June 11, 2026. The filing indicates a proposed sale of 140 shares of common stock, acquired on December 31, 2024, through an open market purchase, with an aggregate market value of $1443.00. The transac", "url": "https://www.stocktitan.net/sec-filings/NVNO/144-en-v-veno-medical-corp-sec-filing-0c0ce7d75e01.html", "source_name": "Stock Titan", "published_at": "2026-06-11T15:39:52", "published_display": "11 Jun 2026 15:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Spotting Winners: Enovis (NYSE:ENOV) And Medical Devices & Supplies - Specialty Stocks In Q1", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxQRWNsVUM3aGV5UmJHYUowOWtNRU11RzZSalpyampRQ3ZQTlBNV05zSHo4MTJJS0JqTV92LWV3MUdXWkRIckNNZi1aeVg1TmtKNFpoS3g5dTBXRW1BZXRMWGo1SVl2NjNaQ2NSNV90V0MtMzBEQndVclZzUUVXbi1FU0lyU0FndlAwaXNfUVpOTXBEZWQtQVpmanRoU0JjLWxlakFJSQ?oc=5", "source_name": "Market source", "published_at": "2026-06-11T07:00:00+00:00", "published_display": "11 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "enVVeno Medical Reports Full Year 2025 Financial Results and Highlights Strategic Advancement of enVVe(R) System", "summary": "enVVeno Medical Corporation announced its financial results for the full year 2025, reporting a net loss of $19.5 million and $28.2 million in cash and investments. The company accelerated the development of its enVVe\u00ae System, a less invasive transcatheter replacement venous valv", "url": "https://www.phillyburbs.com/press-release/story/50200/envveno-medical-reports-full-year-2025-financial-results-and-highlights-strategic-advancement-of-envver-system/", "source_name": "PhillyBurbs", "published_at": "2026-06-04T05:40:10", "published_display": "04 Jun 2026 05:40", "sentiment": "positive", "sentiment_pct": 72, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "enVVeno Medical to Participate in the Virtual Investor Closing Bell Series", "summary": "enVVeno Medical (NASDAQ:NVNO) announced that CEO Robert Berman will participate in a Virtual Investor Closing Bell event on June 9, 2026, at 4:00 PM ET. He will discuss the recent FDA IDE approval for the enVVe\u00ae System, a non-surgical replacement venous valve, and engage in a liv", "url": "https://www.accessnewswire.com/newsroom/en/biotechnology/envveno-medical-to-participate-in-the-virtual-investor-closing-bell-series-1172665", "source_name": "ACCESS Newswire", "published_at": "2026-06-02T13:38:59", "published_display": "02 Jun 2026 13:38", "sentiment": "positive", "sentiment_pct": 71, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "NVNO - enVVeno Medical Corp Stock Price and Quote", "summary": "This article provides a detailed stock price, quote, and company overview for enVVeno Medical Corp (NVNO). It includes financial metrics, stock performance data, and a chronological list of recent news and press releases related to the company's developments, FDA approvals, and f", "url": "https://finviz.com/stock?t=NVNO", "source_name": "Finviz", "published_at": "2026-06-01T16:10:52", "published_display": "01 Jun 2026 16:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "enVVeno Medical Reports First Quarter 2026 Financial Results and Provides Business Update Highlighting Strategic Advancement of the enVVe System", "summary": "enVVeno Medical reported its first-quarter 2026 financial results, ending the period with approximately $25 million in cash and investments, which is expected to fund operations into Q3 2027. The company highlighted receiving FDA IDE approval for its TAVVE U.S. Pivotal Study for ", "url": "https://www.biospace.com/press-releases/envveno-medical-reports-first-quarter-2026-financial-results-and-provides-business-update-highlighting-strategic-advancement-of-the-envve-system", "source_name": "BioSpace", "published_at": "2026-05-26T01:11:28", "published_display": "26 May 2026 01:11", "sentiment": "positive", "sentiment_pct": 70, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "enVVeno Medical (NVNO) Q3 2025 Earnings: Narrower-Than-Expected Loss Signals Cost Discipline Progress - Return On Assets", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2wFBVV95cUxQTC13SVNKaEVKTENxYW1GcjE3Zm5DT1F0ZW5fME1PZklTM2lYcXNCVHIzX0NNS01CMjY2WFRGNmN3R1dyZmk5cWVjWkstTHRtUm9pMEd1eDY0c3hUVXpoYzktVXpjTURrUUdVOEJjdjZfYkFNaG5nYkpwYnFxbTZHTTltUjNsdk44Rl9DV0hIQkRIOEJXOEJRZFJKZlBjYTVsX2Y2X0RHRF9scUFuY2tjVDF0cENlc01pX05rWFFLaG5hMG5xWm5RdVFxblZVdW41TTRMVk9aRkY3akk?oc=5", "source_name": "Donan\u0131mHaber", "published_at": "2026-05-23T07:00:00+00:00", "published_display": "23 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Specialty Stocks Q1 Highlights: Haemonetics (NYSE:HAE)", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxNMTBnNnM2WGg4UWl4LXNNdUdWLVozU3ptQlRZQTk2SFFsOEZTLTVlbU5tNnhSTVRXX3RYczQ5b2hCR254bS1QYmZqV2JfdVFYTEx2U0hFeW1VREwybmRDWEE3MEpSWldySDJNTHFXbWcta2tNY0cwM0hVWld5VnVOWE1zY1VNQS1wQkIyZHN5a0dRNktDdnBvaTcyY3RKa292aThMTmNGeUpUUVU1Unhr?oc=5", "source_name": "Market source", "published_at": "2026-05-22T07:00:00+00:00", "published_display": "22 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q1 Earnings Review: Medical Devices & Supplies - Diversified Stocks Led by Baxter (NYSE:BAX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNYjhBT3BjMWFVU1FFUUFub0d6QUVEUTdwWFVMRG5fN2dHSnIxTXQwMWU1aElKaEV1a2dYLTFHMlBzMVFTZEtaX0xRRDFhZDl1WFdDYWF2RDZxOG9SRUtycmZacTRzM2FaaEU3OS1GZ2taLWtSMjZ4enhVNHRvdzJsanp4cEhNcGI1dllTOUplWUUtNjRlRm85MlFEVWxSYUV2d243QVd3?oc=5", "source_name": "Market source", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Specialty Stocks Q1 Teardown: Bausch + Lomb (NYSE:BLCO) Vs The Rest", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxPUFI2R08xV3JsZHYxbnFGcmk1Q3prRzBQVVlJNk5NTFlYOXBaczlzZE1PREIxb0loeUNQeUw3QWczNUowYXlEOU1KY1dTY2gybUQ5OEM0Z3Z2TlNleUVIRWJMc0VqZTdZcnVOZ2JBeUpIeFNCVjk3SVYxTmc5SG1RTjBHY2l3QkdxX09lZkpMekpYOElqQmJHc0dHUm8tVzJzSFZRaUdZZzNodTdyRjZz?oc=5", "source_name": "Market source", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Perceptive entities disclose 9.99% stake in enVVeno (NASDAQ: NVNO)", "summary": "Perceptive Advisors, Joseph Edelman, and Perceptive Life Sciences Master Fund, Ltd. have filed a Schedule 13G/A, disclosing a beneficial ownership of 9.99% in enVVeno Medical Corporation (NASDAQ: NVNO). This stake, based on 667,669 outstanding shares as of May 1, 2026, is constra", "url": "https://www.stocktitan.net/sec-filings/NVNO/schedule-13g-a-en-v-veno-medical-corp-amended-passive-investment-disc-b4d8dc23f4e1.html", "source_name": "Stock Titan", "published_at": "2026-05-15T19:40:44", "published_display": "15 May 2026 19:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kingdon group holds 36,166 shares in enVVeno (NASDAQ: NVNO)", "summary": "Kingdon-affiliated parties have disclosed beneficial ownership of 36,166 shares in enVVeno Medical Corp (NASDAQ: NVNO), amounting to a 5.5% stake in the company's common stock. This information was reported through an amended Schedule 13G/A filing with the SEC, indicating shared ", "url": "https://www.stocktitan.net/sec-filings/NVNO/schedule-13g-a-en-v-veno-medical-corp-amended-passive-investment-disc-f96caf213ffb.html", "source_name": "Stock Titan", "published_at": "2026-05-15T17:40:44", "published_display": "15 May 2026 17:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "enVVeno Medical Discusses FDA IDE Approval in Virtual Investor \"What This Means\" Segment", "summary": "enVVeno Medical announced that CEO Robert Berman discussed the company's recent FDA IDE approval for a US pivotal study of a non-surgical replacement venous valve during a Virtual Investor \"What This Means\" segment. This approval is a significant step towards developing the first", "url": "https://www.accessnewswire.com/newsroom/en/biotechnology/envveno-medical-discusses-fda-ide-approval-in-virtual-investor-%22what-this-means%22-segm-1166040", "source_name": "ACCESS Newswire", "published_at": "2026-05-12T13:10:39", "published_display": "12 May 2026 13:10", "sentiment": "positive", "sentiment_pct": 71, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "One enVVeno Medical Insider Raised Their Stake In The Previous Year", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/one-envveno-medical-insider-raised-185848824.html", "source_name": "Simply Wall St.", "published_at": "2026-05-06T18:58:48+00:00", "published_display": "06 May 2026 18:58", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Diversified Stocks Q1 Results: Benchmarking Stryker (NYSE:SYK)", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2wFBVV95cUxNb1NaVXV6UW42emtDUzh5ckhKVjc2X29fSlFRRDVIVnRLWXpoWEYxUnVKNGZuLVN6ZWhxVno1SGluMEdLcmNrOGN1ZjlsWFpVRWxYbW9aYy01VFFpVzlncWtBYzF3YkJfNzhwTi1BcWlpVF9pUTU4QnNGWkJSV3YwRXVCUzk2Z2NUMWFjVkJOV2hSbFRrRnIxSWxNUGRoQmhQeDVBRjhYSnhvMDJqUThjYjBHRjhTRTBDdDZJd1k3LU5DTjU2cUx6TXFNdHhVS1FfdlFmaWZLNk41cFk?oc=5", "source_name": "StockStory", "published_at": "2026-05-05T07:00:00+00:00", "published_display": "05 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "enVVeno Medical Receives First-Ever FDA IDE Approval for a U.S. Pivotal Study of a Non-Surgical Replacement Venous Valve", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/envveno-medical-receives-first-ever-120500979.html", "source_name": "ACCESS Newswire", "published_at": "2026-04-29T12:05:00+00:00", "published_display": "29 Apr 2026 12:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Specialty Q4 Earnings: Globus Medical (NYSE:GMED) is the Best in the Biz", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNcDFMNmtOVk5PVFM1YzMyVWhyS3dwY0dMVE5BUng5U1JoOFRQMXNFRGxTMmlBRUV0bENRSWFXTDFZOXBQQkNZT0FOWDdISjRCcU9pRV9aNHBwUVBuZkVEV3g1dklVY19KOE9iWUNpNUtMS2NuOEcxMlQtNU8ydURybEdkNVoxZThWLTBIeVhid2NjQ0FWWTUzb2dxcmlMQThFQmZ4bldzRjcwUQ?oc=5", "source_name": "Market source", "published_at": "2026-04-27T07:00:00+00:00", "published_display": "27 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look Back at Medical Devices & Supplies - Imaging, Diagnostics Stocks\u2019 Q4 Earnings: Hologic (NASDAQ:HOLX) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxOdkl6Ym5HSGVhZUw3TzNlNVFPSjdDQk5NMTVSRW1xVnh3RE5RNU9veVR0TDEtcVdxV3BYelI0bWxCYXgwWmhZQ3ZONUVRdlhjX0ZiMklRVDJQRXN0LXcyVWVnb0E2WTdiRERtZk1pNGpmVHhWbHl5eHJuNnBtTDVPMUluTmRsQUVqYjNlSl8zR3djclh0X2ZIc1gzTlhPanR6ZTJ6R1FB?oc=5", "source_name": "Market source", "published_at": "2026-04-07T07:00:00+00:00", "published_display": "07 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q4 Earnings Highlights: Artivion (NYSE:AORT) Vs The Rest Of The Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxPaTgxS3dlMlZ5dDZ3dFlGdG9yRWFubkVqMk9yOTN6OEtyemljTWJGYUcxb2pmd2FTNTFKMlhIVGxrdlJsOG5iY1VQaXE4ZmYycTVpRkE0aEJ3QlB5bC10ZXN2dTFYNy0wRWdrNURVUlo5dEMzQklxQ0kwQTRkOXE0UDdTMkRGRWxoQ1ZQeG4tOXNONlR2SkxfZW5ST1B6N3BBeFZZQ3N1UFE?oc=5", "source_name": "Market source", "published_at": "2026-04-02T07:00:00+00:00", "published_display": "02 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q4 Rundown: Bausch + Lomb (NYSE:BLCO) Vs Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOd1pNRFRBVUF2RG5RNWNhSVJaWFM5aUFRVF9xSF8zVHVMcVBoSXdaRXJrbV8wLUFOS2tHOHIzZEhZSF9rZ2dVbVNIOEdEbE9GMmpsMEtIUE9OTGRjcUlyVnNSa2FyX3hjcmF2YTNDOGQ1UDVjMHI4ak44bUl1bnVoQ3VfSjZGMXR5T19xOWkzaUtSZ2NiMF80bUtvVWU?oc=5", "source_name": "Market source", "published_at": "2026-04-02T07:00:00+00:00", "published_display": "02 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q4 Earnings Highlights: CooperCompanies (NASDAQ:COO) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxOellVLTAtRXF1dTFacmVLUmptUVpDSkxGX0MtY2hCY2l3ajU4M25SMG95OHdlc1RHN1dmaHZZMF9uQ0o3R1FBa0NzQUtZMjIzMjU1bmttbGZsZUplQkd5Vmd2NEJoQ0NnbVhmVXppdWhiQkdpcGpQVFJVSHRBXy1pbnFJbXI0R2w3MmlvMEdCY2dGYVE4cWY2MENmeEp1ME9mZEFqSDVtdThTMk9kbUhIdXMtR0k?oc=5", "source_name": "Market source", "published_at": "2026-03-25T07:00:00+00:00", "published_display": "25 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Unpacking Q4 Earnings: Integer Holdings (NYSE:ITGR) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAJBVV95cUxNdFRrRlJvM3J3cGJnVEJ6ZndqMnQxWkE4Wm8zTGtPTVc0OTlLN1pwNXIyclNJMFZkcG5qQTRTWThmNm9WN0hKYXBja3N3Y20zSlkxc2JaQlpYTnAyWnpvUVBvR1JWNmVxZGhSYVlYQklMd01GeFBVNGJWOFBWYUkwYmRrM2xrSktiQWpfTkZtNG1HWThNT0tqLUpYek5qcnFWMGE0QV9CaElrMUpfTEhnOC1pS2t1bkE2VVJHdEhWdEtoX2xKNE1MWk1OSlBSNTVZVU83WEpnb3E4aURwQ3ZyZUFDbndpTTZEa0lZRTJvU2VuTDhreXdCQ25iV3Y4YWxENm1xYQ?oc=5", "source_name": "StockStory", "published_at": "2026-03-16T07:00:00+00:00", "published_display": "16 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q4 Earnings Highs And Lows: Abbott Laboratories (NYSE:ABT) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxPeVpVN2I3X3lJNXd3TXJmRWV4X0RvRDdYR3l5a1k1SjMxUlhsWHdrUUNuZ1JIaUg4czdhZlA2VDVIallROFFuNmZXcnNzS1d3Vm0wS0tLMmlFVWdkUThsRDZYdTdZV3k3WkRjaUZSMUQ3dkRKYm5ZOVBjMVVBdTRjYQ?oc=5", "source_name": "Market source", "published_at": "2026-03-12T07:00:00+00:00", "published_display": "12 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Unpacking Q4 Earnings: Enovis (NYSE:ENOV) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxNMzBPcXU1cnZKekZnaGlNVk05ZWFTWThNOS0tTlpvQjdaLVZIWlVXUk50NnVoQ0pPWWJpZUpWcVJyVDJMd2RJREVDbEEzTlU5UGhBbWtxWVEyVkdaMTVuNXZpaWFMNTZUQ2d0OW9Rc29kalJRY21naWlHZDBLS3RuZV9wdTdIUQ?oc=5", "source_name": "Market source", "published_at": "2026-03-10T07:00:00+00:00", "published_display": "10 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q4 Highlights: Merit Medical Systems (NASDAQ:MMSI)", "summary": "", "url": "https://news.google.com/rss/articles/CBMilgFBVV95cUxQdTQyU1EtSEFYQTdZR0NhU1ZpMVdGNXhiTnlkNm9RWFRka3RfYlZBeklfTFZTRkVaOHBGNi15enNqMGlxVnJad0M5cmp3dUZzYW9Va2tOU19sMnE4V1czcFB4VWRKaVBzYnRtZ0RfVnB5TkloY3U5dW4wQllJMDJaS3BQSVNOMHlVRFQ4aDYtSV9HNTViZXc?oc=5", "source_name": "Market source", "published_at": "2026-03-05T08:00:00+00:00", "published_display": "05 Mar 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "enVVeno Medical Announces Reverse Stock Split", "summary": "", "url": "https://news.google.com/rss/articles/CBMijgFBVV95cUxObGVub0hmNm1UenF1enAxRzY1NldoZF8zRjFrclRwNnFNY2REaGhSQ3YtNG0ySlY0OExFQWt2c1BleFdwZXZlXzFJTnNrNjJrMFpOdUdFb3RoTzJsa0JqNTNZZEh5Wlg2TkRDQzc2LWpzeTRoX3dMSDJNWHRBb0N1V0t3a3EzVFNCbFVVNDFB?oc=5", "source_name": "Market source", "published_at": "2026-01-15T08:00:00+00:00", "published_display": "15 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Should I buy enVVeno Medical (NVNO)", "summary": "", "url": "https://news.google.com/rss/articles/CBMibEFVX3lxTE5CLXFMQ005aFJ5ZXdsOHluUWdPb1l2LWZFVVlSbi0tTjJCZ2d2RHVhQXV5Mzk3bmFFR0RZcG1SMHFIRmt4OFRsNkpkNTI0YWhqRVRwZUdaMng0bm1TbXV5R0Q3eXhKSkNKQjRYcQ?oc=5", "source_name": "Zacks Investment Research", "published_at": "2025-08-25T07:00:00+00:00", "published_display": "25 Aug 2025 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Envveno Medical Corporation (NVNO) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE5CcldPbGg5Ymc5TlVISjl6RldzXzdjYXZER1VBSTFzekhNNUFMVWl0YzVDMi16N3FCRnQ2SVlEZW56N052NHNOZ3QyQWxTdzUxRC00?oc=5", "source_name": "Stock Titan", "published_at": "2025-04-25T02:37:16+00:00", "published_display": "25 Apr 2025 02:37", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "enVVeno Medical (NVNO) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiWkFVX3lxTE5HMVdJVXFKa2JSNjRRRGM1MWQzZWFqZ0xwT2F2RGZXNThuREQ0RkdUZElDS01qcE1OWkVoVzVIdWpxMlkwbUVscEZOQVBqQTBzdGxMM0gyRXRHdw?oc=5", "source_name": "MarketBeat", "published_at": "2021-10-02T17:34:54+00:00", "published_display": "02 Oct 2021 17:34", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 85, "total_relevant": 59, "sentiment_summary": {"positive": 12, "negative": 3, "neutral": 44, "score": 55, "total": 59, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 77, "events": [{"event": "general", "label": "Market update", "weight": 16.1, "count": 28}, {"event": "earnings", "label": "Earnings", "weight": 11.55, "count": 21}, {"event": "regulatory", "label": "Regulatory and legal", "weight": 3.3, "count": 6}, {"event": "deals", "label": "Deals and strategy", "weight": 1.65, "count": 3}, {"event": "analyst", "label": "Analyst action", "weight": 0.55, "count": 1}], "positive_events": 12, "negative_events": 3}, "market_context": {"has_market_context": true, "latest_close": 11.36, "latest_week": "2026-07-10", "one_week_move": 2.3, "four_week_move": 13.6, "twelve_week_move": -2.9, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 0.78644, "market_dynamics_buy_signal": false, "relative_strength": -69.927152, "fair_value_gap": -89.7, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "undecided", "expectation_probability": 46.5407, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+2.3% over one week, +13.6% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 63, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Market source", "count": 16}, {"label": "TradingView", "count": 10}, {"label": "Stock Titan", "count": 9}, {"label": "ACCESS Newswire", "count": 5}, {"label": "StockStory", "count": 2}, {"label": "marketscreener.com", "count": 1}, {"label": "Investing.com Nigeria", "count": 1}, {"label": "News-Press NOW", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 59}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 28}, {"label": "Earnings", "count": 21}, {"label": "Regulatory and legal", "count": 6}, {"label": "Deals and strategy", "count": 3}, {"label": "Analyst action", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "55/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "77/100 classification confidence."}, {"label": "Company focus", "value": "59", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "2", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+2.3% over one week, +13.6% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "EnVVeno Medical : Highlights Newly Issued U.S. Patent Strengthening Competitive Position Ahead of Historic Pivotal Trial in Virtual Investor \"What This Means\" Segment"}], "updated_at": "2026-07-15T23:34:09.235656+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}